| 摘要 |
<p>A method for treating an immunopathological disorder having an etiology associated with production of a proinflammatory agent, in a subject by administering a therapeutically effective amount of radicicol to the subject is provided herein. Typically, the disorder is associated with production of tumor necrosis factor alpha (TNF-α) and/or cyclooxygenase-2 (COX-2).</p> |
